派博傳思國際中心

標(biāo)題: Titlebook: Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease; An Overview and Upda Corey R. Hopkins Book 2016 Springer Internationa [打印本頁]

作者: Coarctation    時(shí)間: 2025-3-21 19:57
書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease影響因子(影響力)




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease影響因子(影響力)學(xué)科排名




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease網(wǎng)絡(luò)公開度




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease被引頻次




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease被引頻次學(xué)科排名




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease年度引用




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease年度引用學(xué)科排名




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease讀者反饋




書目名稱Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease讀者反饋學(xué)科排名





作者: 慎重    時(shí)間: 2025-3-21 22:49
1862-2461 in the field.Volumes are useful and of relevance for a longMedicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need fo
作者: 不利    時(shí)間: 2025-3-22 00:26
Corey R. HopkinsOverview chapters introduce the newcomer to the topic covered.Series covers hot topics of frontier research summarized by reputed scientists in the field.Volumes are useful and of relevance for a long
作者: TERRA    時(shí)間: 2025-3-22 06:25
Topics in Medicinal Chemistryhttp://image.papertrans.cn/n/image/668466.jpg
作者: GULP    時(shí)間: 2025-3-22 12:35

作者: JIBE    時(shí)間: 2025-3-22 14:48
978-3-319-81998-3Springer International Publishing Switzerland 2016
作者: Osteons    時(shí)間: 2025-3-22 19:00
Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease978-3-319-39926-3Series ISSN 1862-2461 Series E-ISSN 1862-247X
作者: foliage    時(shí)間: 2025-3-23 00:45

作者: 有法律效應(yīng)    時(shí)間: 2025-3-23 04:57
Novel Therapeutic Approaches to the Treatment of Parkinson’s DiseaseAn Overview and Upda
作者: 津貼    時(shí)間: 2025-3-23 06:07
1862-2461 eractionson the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known g978-3-319-81998-3978-3-319-39926-3Series ISSN 1862-2461 Series E-ISSN 1862-247X
作者: 察覺    時(shí)間: 2025-3-23 11:19

作者: BOON    時(shí)間: 2025-3-23 15:51
Adenosine A2A Receptor Antagonists,ches to dual A./A. antagonists and A./MAO-B will also be highlighted. The in vivo profiles of compounds will be highlighted and discussed to compare activities across different chemical series. A clinical report and update will be given on compounds that have entered clinical trials.
作者: 細(xì)絲    時(shí)間: 2025-3-23 19:37
,Targeting α-Synuclein as a Parkinson’s Disease Therapeutic,estigation that aim to maintain physiological α-synuclein levels, limit toxic aggregates, and lessen effects of misfolded α-synuclein on cellular homeostasis. For example, oligonucleotide-based approaches limit α-synuclein gene expression. In addition, select small molecules and peptides inhibit α-s
作者: addict    時(shí)間: 2025-3-23 23:58

作者: 得體    時(shí)間: 2025-3-24 03:55

作者: Cupidity    時(shí)間: 2025-3-24 07:20
Adenosine A2A Receptor Antagonists, still are, a promising non-dopaminergic approach for the potential treatment of Parkinson’s disease. There have been numerous publications, patent applications, and press releases that highlight new medicinal chemistry approaches to this attractive and promising target to treat Parkinson’s disease.
作者: 散布    時(shí)間: 2025-3-24 14:21

作者: 消毒    時(shí)間: 2025-3-24 18:25

作者: NATTY    時(shí)間: 2025-3-24 20:20
nce of ‘big business’, with the Commission’s Directorate-General for Enterprise and Industry being in the firing line (e.g., ALTEREU, 2013). Interestingly, however, DG Enterprise’s work with the expert group discussed in this chapter proves quite the contrary. So far, this book has examined two expe
作者: dragon    時(shí)間: 2025-3-25 01:13
6樓
作者: cloture    時(shí)間: 2025-3-25 03:25
7樓
作者: 壟斷    時(shí)間: 2025-3-25 09:00
7樓
作者: Incorruptible    時(shí)間: 2025-3-25 13:56
7樓
作者: deadlock    時(shí)間: 2025-3-25 16:03
7樓
作者: prick-test    時(shí)間: 2025-3-25 22:54
8樓
作者: obstinate    時(shí)間: 2025-3-26 01:59
8樓
作者: 終點(diǎn)    時(shí)間: 2025-3-26 04:41
8樓
作者: Highbrow    時(shí)間: 2025-3-26 09:28
8樓
作者: 男生如果明白    時(shí)間: 2025-3-26 14:37
9樓
作者: paragon    時(shí)間: 2025-3-26 16:48
9樓
作者: 射手座    時(shí)間: 2025-3-26 22:18
9樓
作者: Gorilla    時(shí)間: 2025-3-27 01:53
9樓
作者: 綁架    時(shí)間: 2025-3-27 06:29
10樓
作者: VERT    時(shí)間: 2025-3-27 12:54
10樓
作者: 點(diǎn)燃    時(shí)間: 2025-3-27 13:49
10樓
作者: 團(tuán)結(jié)    時(shí)間: 2025-3-27 18:28
10樓




歡迎光臨 派博傳思國際中心 (http://www.yitongpaimai.cn/) Powered by Discuz! X3.5
巴南区| 泽库县| 禄丰县| 九江市| 临西县| 驻马店市| 吴桥县| 湾仔区| 温宿县| 麟游县| 临湘市| 江川县| 南靖县| 海口市| 龙游县| 保德县| 金秀| 忻州市| 布拖县| 辽阳市| 桂林市| 胶南市| 闻喜县| 淮南市| 夏津县| 哈巴河县| 达尔| 城市| 辽源市| 汉源县| 怀仁县| 龙门县| 安国市| 英吉沙县| 大方县| 南涧| 博乐市| 积石山| 关岭| 武安市| 牙克石市|